EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 82.90
+0.80 (0.97%)
At close: May 12, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 2.41 billion as of May 13, 2025. Its market cap has increased by 95.06% in one year.
Market Cap
2.41B
Enterprise Value
2.78B
Revenue
373.52M
Ranking
n/a
PE Ratio
57.57
Stock Price
82.90
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 2.41B, an increase of 2,980.16%. That is a compound annual growth rate of 35.05%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 104.27B |
| Sectra AB | 59.53B |
| Getinge AB | 52.98B |
| Camurus AB | 36.97B |
| Medicover AB | 36.18B |
| AddLife AB | 23.20B |
| Vitrolife AB | 21.41B |
| Vimian Group AB | 20.31B |